Literature DB >> 32764943

Hollow Prussian Blue Nanospheres for Photothermal/Chemo-Synergistic Therapy.

Long Lu1, Chuanbin Zhang1, Bingfang Zou1,2, Yongqiang Wang1.   

Abstract

BACKGROUND: The integration of NIR photothermal therapy and chemotherapy is considered as a promising technique for future cancer therapy. Hollow Prussian nanospheres have attracted much attention due to excellent near-infrared photothermal conversion effect and drug-loading capability within an empty cavity. However, to date, the hollow Prussian nanospheres have been prepared by a complex procedure or in organic media, and their shell thickness and size cannot be controlled. Thus, a simple and controllable route is highly desirable to synthesize hollow Prussian nanospheres with controllable parameters.
MATERIALS AND METHODS: Here, in our designed synthesis route, the traditional FeCl3 precursor was replaced with Fe2O3 nanospheres, and then the Prussian blue (PB) nanoparticles were engineered into hollow-structured PB (HPB) nanospheres through an interface reaction, where the Fe2O3 colloidal template provides Fe3+ ions. The reaction mechanism and control factors of HPB nanospheres were systematically investigated. Both in vitro and in vivo biological effects of the as-synthesized HPB nanospheres were evaluated in detail.
RESULTS: Through systematical experiments, a solvent-mediated interface reaction mechanism was put forward, and the parameters of HPB nanospheres could be easily adjusted by growth time and template size under optimal water and ethanol ratio. The in vitro tests show the rapid and remarkable photothermal effects of the as-prepared HPB nanospheres under NIR laser irradiation (808 nm). Meanwhile, HPB nanospheres also demonstrated a high DOX loading capacity of 440 mg g-1 as a drug carrier, and the release of the drug can be regulated by the heat from PB shell under the exposure of an NIR laser. The in vivo experiments confirmed the outstanding performance of HPB nanospheres in photothermal/chemo-synergistic therapy of cancer.
CONCLUSION: A solvent-mediated template route was developed to synthesize hollow Prussian blue (HPB) nanospheres in a simple and controllable way. The in vitro and in vivo results demonstrate the as-synthesized HPB nanospheres as a promising candidate due to their low toxicity and high efficiency for cancer therapy.
© 2020 Lu et al.

Entities:  

Keywords:  Prussian blue; chemotherapy; hollow nanospheres; photothermal therapy; template

Mesh:

Substances:

Year:  2020        PMID: 32764943      PMCID: PMC7373408          DOI: 10.2147/IJN.S252505

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  32 in total

Review 1.  Functionalized mesoporous silica materials for controlled drug delivery.

Authors:  Piaoping Yang; Shili Gai; Jun Lin
Journal:  Chem Soc Rev       Date:  2012-03-22       Impact factor: 54.564

2.  Perfluoropentane-encapsulated hollow mesoporous prussian blue nanocubes for activated ultrasound imaging and photothermal therapy of cancer.

Authors:  Xiaoqing Jia; Xiaojun Cai; Yu Chen; Shige Wang; Huixiong Xu; Kun Zhang; Ming Ma; Huixia Wu; Jianlin Shi; Hangrong Chen
Journal:  ACS Appl Mater Interfaces       Date:  2015-02-23       Impact factor: 9.229

3.  PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy.

Authors:  Liang Cheng; Hua Gong; Wenwen Zhu; Jingjing Liu; Xiaoyong Wang; Gang Liu; Zhuang Liu
Journal:  Biomaterials       Date:  2014-09-16       Impact factor: 12.479

4.  Mn2+-doped prussian blue nanocubes for bimodal imaging and photothermal therapy with enhanced performance.

Authors:  Wenwen Zhu; Kai Liu; Xiaoqi Sun; Xin Wang; Yonggang Li; Liang Cheng; Zhuang Liu
Journal:  ACS Appl Mater Interfaces       Date:  2015-05-20       Impact factor: 9.229

Review 5.  Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials.

Authors:  Duarte de Melo-Diogo; Cleide Pais-Silva; Diana R Dias; André F Moreira; Ilídio J Correia
Journal:  Adv Healthc Mater       Date:  2017-03-21       Impact factor: 9.933

6.  Drug "Pent-Up" in Hollow Magnetic Prussian Blue Nanoparticles for NIR-Induced Chemo-Photothermal Tumor Therapy with Trimodal Imaging.

Authors:  Jinghua Li; Fengshou Zhang; Zhigang Hu; Weidong Song; Guangda Li; Gaofeng Liang; Jun Zhou; Ke Li; Yang Cao; Zhong Luo; Kaiyong Cai
Journal:  Adv Healthc Mater       Date:  2017-05-02       Impact factor: 9.933

Review 7.  Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy.

Authors:  Guosheng Song; Liang Cheng; Yu Chao; Kai Yang; Zhuang Liu
Journal:  Adv Mater       Date:  2017-06-23       Impact factor: 30.849

8.  Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.

Authors:  Guanglei Fu; Wei Liu; Shanshan Feng; Xiuli Yue
Journal:  Chem Commun (Camb)       Date:  2012-12-07       Impact factor: 6.222

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

10.  Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.

Authors:  Brian T Luk; Ronnie H Fang; Che-Ming J Hu; Jonathan A Copp; Soracha Thamphiwatana; Diana Dehaini; Weiwei Gao; Kang Zhang; Shulin Li; Liangfang Zhang
Journal:  Theranostics       Date:  2016-04-28       Impact factor: 11.556

View more
  3 in total

1.  Manganese-Based Prussian Blue Nanocatalysts Suppress Non-Small Cell Lung Cancer Growth and Metastasis via Photothermal and Chemodynamic Therapy.

Authors:  Danruo Fang; Zeyu Liu; Hansong Jin; Xiulin Huang; Yongxin Shi; Suqin Ben
Journal:  Front Bioeng Biotechnol       Date:  2022-06-22

2.  Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis.

Authors:  Wenhao Shen; Gaohua Han; Lei Yu; Song Yang; Xiangyi Li; Wei Zhang; Pei Pei
Journal:  Int J Nanomedicine       Date:  2022-03-25

Review 3.  Synthesis of Prussian Blue Nanoparticles and Their Antibacterial, Antiinflammation and Antitumor Applications.

Authors:  Danyang Li; Meng Liu; Wenyao Li; Qiang Fu; Liyang Wang; Enping Lai; Weixin Zhao; Kaile Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.